At a glance
- Originator Uriach
- Class Antifungals
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 17 Dec 1997 Discontinued-I for Mycoses in Spain (PO)
- 19 Nov 1996 Phase-I clinical trials for Mycoses in Spain (PO)
- 01 Jun 1995 New profile